
Final 2-Year TELIGAN Data for Telitacicept in IgA Nephropathy
0:00
15:54
Welcome back to Kidney Compass!
Recording from ASN Kidney Week 2026 in Denver, Colorado, cohosts Brendon Neuen, MBBS, PhD, and Shikha Wadhwani, MD, MS, welcomed back Jicheng Lv, MD, of Peking University First Hospital, after he presented final 2-year results from the phase 3 TELIGAN trial during the late-breaking plenary.
Więcej odcinków z kanału "Kidney Compass: Navigating Clinical Trials"



Nie przegap odcinka z kanału “Kidney Compass: Navigating Clinical Trials”! Subskrybuj bezpłatnie w aplikacji GetPodcast.








